Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial
Збережено в:
Hjorthøj, C.R., ET AL., Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction, Vol. 107, no. 6 (2012), p. 1123-1131.
Ref.
186080
Локація:
SIIS R.696 Archivo
Palabras clave:
Análisis clínicos, Autoinformes, Cannabis, Detección, Diagnóstico dual, Drogas ilegales, Drogodependencias, Enfermedades mentales, Evaluación, Sangre
Análisis clínicos, Autoinformes, Cannabis, Detección, Diagnóstico dual, Drogas ilegales, Drogodependencias, Enfermedades mentales, Evaluación, Sangre
Схожі ресурси: Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial
- Estimating thresholds for risk of cannabis use disorder using standard delta-9-tetrahydrocannabinol (THC) units
- Enhanced cannabis timeline followback (EC-TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures
- ORAL DELTA 9 TETRAHYDROCANNABINOL SUPPRESSES CANNABIS WITHDRAWAL SYMPTOMS
- Timeline FollowBack for Gambling (TLFB)
- ETHANOL INCREASES PLASMA A-TETRAHYDROCANNABINOL (THC) LEVELS AND SUBJECTIVE EFFCTS AFTER MARIHUANA SMOKING IN HUMAN VOLUNTEERS
- DELTA-9-TETRAHYDROCANNABINOL EFFECTS IN SCHIZOPHRENIA: IMPLICATIONS FOR COGNITION, PSYCHOSIS, AND ADDICTION